
Liquidity, historical trends, and peer comparisons.
According to Poolbeg Pharma PLC’s latest financial reports and current stock price. The company's current Current Ratio is 12.44. This represents a change of -4.95% compared to the average of 13.08 of the last 4 quarters.
The mean historical Current Ratio of Poolbeg Pharma PLC over the last ten years is 19.08. The current 12.44 Current Ratio has changed -34.82% with respect to the historical average. Over the past ten years (40 quarters), POLBF's Current Ratio was at its highest in in the June 2021 quarter at 175.07. The Current Ratio was at its lowest in in the December 2025 quarter at 6.17.
Average
19.08
Median
13.69
Minimum
6.17
Maximum
48.98
Discovering the peaks and valleys of Poolbeg Pharma PLC Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Current Ratio = 48.98
Minimum Annual Increase = -63.75%
Minimum Annual Current Ratio = 6.17
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 6.17 | -29.87% |
| 2024 | 8.79 | -35.78% |
| 2023 | 13.69 | -22.91% |
| 2022 | 17.76 | -63.75% |
The current Current Ratio of Poolbeg Pharma PLC (POLBF) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
9.55
5-year avg
19.08
10-year avg
19.08
Poolbeg Pharma PLC’s Current Ratio is greater than Paradigm Biopharmaceuticals Limited (1.10), greater than Kintor Pharmaceutical Limited (0.26), greater than Satellos Bioscience Inc. (11.22), greater than VitaSpring Biomedical Co. Ltd. (0.01), greater than Imugene Limited (0.70), greater than Shield Therapeutics plc (0.75), greater than Senzime AB (publ) (2.84), greater than Starpharma Holdings Limited (3.40), greater than Nuo Therapeutics, Inc. (1.28), greater than Pacific Edge Limited (2.02),
| Company | Current Ratio | Market cap |
|---|---|---|
| 1.10 | $7.45M | |
| 0.26 | $76.61M | |
| 11.22 | $96.62M | |
| 0.01 | $6.58M | |
| 0.70 | $13.08M | |
| 0.75 | $46.62M | |
| 2.84 | $36.98M | |
| 3.40 | $134.98M | |
| 1.28 | $60.91M | |
| 2.02 | $167.59M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Poolbeg Pharma PLC using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Poolbeg Pharma PLC or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Poolbeg Pharma PLC's Current Ratio?
How is the Current Ratio calculated for Poolbeg Pharma PLC (POLBF)?
What is the highest Current Ratio for Poolbeg Pharma PLC (POLBF)?
What is the 3-year average Current Ratio for Poolbeg Pharma PLC (POLBF)?
What is the 5-year average Current Ratio for Poolbeg Pharma PLC (POLBF)?
How does the current Current Ratio for Poolbeg Pharma PLC (POLBF) compare to its historical average?